Early research (Phase 1)Study completedNCT03314922What this trial is testingINCB050465 in Japanese Subjects With Previously Treated B-Cell Lymphoma (CITADEL-111)Who this might be right forLymphoma Incyte Corporation 17
Testing effectiveness (Phase 2)Study completedNCT04433156What this trial is testingVR-CAP in the First-line Treatment for Patients With Marginal Zone LymphomaWho this might be right forMarginal Zone Lymphoma Henan Cancer Hospital 26
Testing effectiveness (Phase 2)Ended earlyNCT01812005What this trial is testingAlisertib With and Without Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin LymphomaWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Burkitt Lymphoma+8 more Ohio State University Comprehensive Cancer Center 14
Early research (Phase 1)Enrolling By InvitationNCT07168486What this trial is testingCD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell LymphomasWho this might be right forB-Cell LymphomaDiffuse Large B Cell Lymphoma (DLBCL)Primary Mediastinal Large B-cell Lymphoma (PMBCL)+7 more University of Maryland, Baltimore 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03888105What this trial is testingAssess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer TherapiesWho this might be right forB-cell Non-Hodgkin Lymphoma (B-NHL) Regeneron Pharmaceuticals 515
Early research (Phase 1)WithdrawnNCT00002956What this trial is testingImmunotherapy for Lymphoproliferative Diseases Associated With Epstein-Barr Virus in Patients Who Have Undergone Organ TransplantsWho this might be right forLeukemiaLymphoma University of Alabama at Birmingham
Early research (Phase 1)Ended earlyNCT01116154What this trial is testingVorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+28 more City of Hope Medical Center 30
Not applicableStudy completedNCT00534118What this trial is testingDonor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell TransplantWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Roswell Park Cancer Institute 39
Testing effectiveness (Phase 2)Ended earlyNCT03768505What this trial is testingZandelisib (ME-401) in Subjects With Follicular Lymphoma or Marginal Zone Lymphoma After Failure of Two or More Prior Therapies (TIDAL)Who this might be right forFollicular Lymphoma (FL)Non Hodgkin LymphomaMarginal Zone Lymphoma MEI Pharma, Inc. 169
Large-scale testing (Phase 3)Looking for participantsNCT07029217What this trial is testingReduced Dose Radiation Therapy for People With B-Cell LymphomasWho this might be right forFollicular LymphomaMarginal Zone Lymphoma Memorial Sloan Kettering Cancer Center 375
Testing effectiveness (Phase 2)Study completedNCT01213095What this trial is testingRituximab Maintenance Therapy for Marginal Zone B-cell Lymphoma (MZL)Who this might be right forLymphoma Dong-A University Hospital 48
Early research (Phase 1)Study completedNCT00443976What this trial is testingAurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forNon-Hodgkins LymphomaUnspecified Adult Solid Tumor, Protocol Specific NCIC Clinical Trials Group 35
Testing effectiveness (Phase 2)Study completedNCT03133221What this trial is testing1630GCC: Zydelig Maintenance in B-Cell Non-Hodgkin's Lymphoma After Autologous Stem Cell TransplantationWho this might be right forNon Hodgkin LymphomaFollicular LymphomaIndolent Lymphoma+6 more University of Maryland, Baltimore 17
Testing effectiveness (Phase 2)Study completedNCT00425802What this trial is testingChemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaWho this might be right forLeukemiaLymphoma Memorial Sloan Kettering Cancer Center 61
Testing effectiveness (Phase 2)Study completedNCT00089037What this trial is testingSirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantationWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT01163201What this trial is testingT-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic MalignanciesWho this might be right forHematologic MalignancyAcute Myeloid LeukemiaAcute Lymphocytic Leukemia+14 more Masonic Cancer Center, University of Minnesota
Early research (Phase 1)Looking for participantsNCT06544265What this trial is testingSynKIR-310 for Relapsed/Refractory B-NHLWho this might be right forB Cell LymphomaNHL, AdultMantle Cell Lymphoma+23 more Verismo Therapeutics 36
Testing effectiveness (Phase 2)UnknownNCT00008164What this trial is testingUmbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic AnemiaWho this might be right forChildhood Langerhans Cell HistiocytosisLeukemiaLymphoma+3 more Herbert Irving Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT06442475What this trial is testingLow Dose Mosunetuzumab for the Treatment of Patients With Indolent B-Cell LymphomaWho this might be right forAnn Arbor Stage II Follicular LymphomaAnn Arbor Stage II Marginal Zone LymphomaAnn Arbor Stage III Follicular Lymphoma+6 more University of Washington 20
Testing effectiveness (Phase 2)WithdrawnNCT00301912What this trial is testingBusulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic CancerWho this might be right forAnemiaChronic Myeloproliferative DisordersLeukemia+4 more University of California, San Francisco